1B. In adult outpatients with moderate to severe CD, the AGA suggests the use of vedolizumab over no treatment for the induction and maintenance of remission. |
27 мая 2021 г. · AGA has just released new clinical practice guidelines evaluating therapies for luminal and fistulizing Crohn's disease. |
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. |
This document presents the official recommendations of the American Gastroenterological Association (AGA) on the medical management of moderate to severe ... |
10 нояб. 2016 г. · This document presents the official recommendations of the American Gastroenterological Association (AGA) on the management of Crohn's ... |
The American Gastroenterological Association recently released a guideline on the role of biomarkers in the management of Crohn's disease. |
This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |